Roche has stolen a march on market leader Keytruda by gaining the first immuno-oncology approval in ...
Read moreA new game changing treatment for people with multiple myeloma will now be available on the NHS in E...
Read moreThe only CAR-T cell therapy available for NHS patients in England and Wales for two distinct blood c...
Read morePfizer has announced that it plans to increase the list price of 41 medicines, or 10% of its entire ...
Read moreNHS England’s cost-effectiveness watchdog, (NICE), issued a first draft document saying that it di...
Read moreIn June 2018, Remap Consulting had the pleasure of attending the annual National Institute of Health...
Read moreOccupying a senior technical and leadership role in NICE's drug appraisal programme, Meindert has a ...
Read moreWe are delighted to say that we have received a fabulous response, with 32 responses from at least 1...
Read moreSince 2004, opportunity cost has been reflected in NICE's appraisal process through the specificatio...
Read moreThe Association of British Pharmaceutical Industry has been refused a legal challenge to a cap on th...
Read more